On December 9, 2025, TuHURA Biosciences, Inc. entered a securities purchase agreement to issue 9,462,423 shares of common stock at $1.65 each, raising approximately $8.6 million in the first tranche of funding. The proceeds will be used for working capital and to satisfy a $3.4 million debt obligation.